Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fuzhou Neptunus Fuyao Pharmaceutical is a comprehensive pharmaceutical manufacturing enterprise based in Fuzhou, Fujian Province, China. As a key subsidiary of the Shenzhen Neptunus Bioengineering Group, the company specializes in the production of a wide array of pharmaceutical products, including large-volume injections, small-volume injections, tablets, capsules, and granules. Its extensive portfolio covers critical therapeutic areas such as anti-infectives, cardiovascular health, gastrointestinal disorders, and respiratory treatments. The company operates modern, GMP-certified facilities and is recognized as one of the leading pharmaceutical production bases in Southeast China. With a history spanning several decades, it focuses on providing high-quality generic medicines and essential healthcare products to the domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fuzhou Haiwang Fuyao Pharmaceutical.